Effects of Drug Cessation in Subjects Receiving Fesoterodine for Treatment of Overactive Bladder Symptoms

Cardozo L1, Ryan J2, Hall T3, Ebel Bitoun C4, Kausar I5, Darekar A6, Wagg A7, Whelan L6, Khullar V8

Abstract Category

Detrusor Overactivity

Abstract 348
Non-Discussion Posters
Scientific Non Discussion Poster Session 29
1. King's College Hospital, 2. The Alverton Practice, 3. Knowle House Surgery, 4. Pfizer France, 5. Pfizer Inc, 6. Pfizer Ltd, 7. University of Alberta, 8. St Mary's Hospital